American Journal of HematologyVolume 82, Issue 3 p. 245-246 LetterFree Access Treatment of anemia in myelodysplastic syndrome with darbepoetin and granulocyte colony stimulating factor Shelonitda Rose, Corresponding Author Shelonitda Rose [email protected] UMDNJ-Robert Wood Johnson Medical School, New Brunswick, New JerseyDivision of Hematology, Department of medicine, UMDNJ-Robert Wood Johnson medical School, 1-Robert Wood Johnson Place, New Brunswick, New Jersey 08903, USASearch for more papers by this authorYaqoob Ali, Yaqoob Ali UMDNJ-Robert Wood Johnson Medical School, New Brunswick, New JerseySearch for more papers by this authorBarbara Maffei, Barbara Maffei UMDNJ-Robert Wood Johnson Medical School, New Brunswick, New JerseySearch for more papers by this authorParvin Saidi, Parvin Saidi UMDNJ-Robert Wood Johnson Medical School, New Brunswick, New JerseySearch for more papers by this author Shelonitda Rose, Corresponding Author Shelonitda Rose [email protected] UMDNJ-Robert Wood Johnson Medical School, New Brunswick, New JerseyDivision of Hematology, Department of medicine, UMDNJ-Robert Wood Johnson medical School, 1-Robert Wood Johnson Place, New Brunswick, New Jersey 08903, USASearch for more papers by this authorYaqoob Ali, Yaqoob Ali UMDNJ-Robert Wood Johnson Medical School, New Brunswick, New JerseySearch for more papers by this authorBarbara Maffei, Barbara Maffei UMDNJ-Robert Wood Johnson Medical School, New Brunswick, New JerseySearch for more papers by this authorParvin Saidi, Parvin Saidi UMDNJ-Robert Wood Johnson Medical School, New Brunswick, New JerseySearch for more papers by this author First published: 21 August 2006 https://doi.org/10.1002/ajh.20725Citations: 1AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL REFERENCES 1 Hussain SI. Myelodysplastic syndromes in the elderly. The role of growth factors in management. Leuk Res 1996; 20: 203– 219. 2 Hellstrom-Lindberg E, Birgegard G, Carlsson M, et al. A combination of granulocyte-colony stimulating factor and erythropoietin may synergistically improve the anemia in patients with myelodysplastic syndromes. Leuk Lymphoma 1993; 11: 221– 228. 3 Musto P, Lanza F, Balleari E, et al. Darbepoetin alpha for the treatment of anemia in low-intermediate risk myelodysplastic syndromes. Br J Hematol 2004; 128: 204– 209. 4 Blinder VS, Robez GJ. Hematopoietic growth factors in myelodysplastic syndromes. Curr Hematol Rep 2003; 2: 453– 458. 5 Jakob A, Hirsch FW, Engelhardt M. Successful treatment of a patient with myelodysplastic syndrome (RAEB) with darbepoetin-alfa in combination with pegfilgrastim. Ann Hematol 2005; 84: 694– 695. Citing Literature Volume82, Issue3March 2007Pages 245-246 ReferencesRelatedInformation